| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ATOM | Common Stock | Sale | -$752 | -116 | -0.09% | $6.49 | 135,014 | 01 Mar 2023 | Direct | F1 |
| transaction | ATOM | Common Stock | Sale | -$1,596 | -246 | -0.18% | $6.49 | 134,768 | 01 Mar 2023 | Direct | F1 |
| transaction | ATOM | Common Stock | Sale | -$5,964 | -919 | -0.68% | $6.49 | 133,849 | 01 Mar 2023 | Direct | F1 |
| transaction | ATOM | Common Stock | Sale | -$3,653 | -563 | -0.42% | $6.49 | 133,286 | 01 Mar 2023 | Direct | F1 |
| transaction | ATOM | Common Stock | Options Exercise | $39,000 | +10,000 | +7.5% | $3.9 | 143,286 | 01 Mar 2023 | Direct | F2 |
| transaction | ATOM | Common Stock | Sale | -$63,300 | -10,000 | -6.98% | $6.33 | 133,286 | 01 Mar 2023 | Direct | F3 |
| transaction | ATOM | Common Stock | Sale | -$16,884 | -2,800 | -2.1% | $6.03 | 130,486 | 02 Mar 2023 | Direct | F3 |
| holding | ATOM | Common Stock | 2,666 | 01 Mar 2023 | by Spouse |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ATOM | Employee Stock Option (right to buy) | Options Exercise | $0 | -10,000 | -17.57% | $0 | 46,923 | 01 Mar 2023 | Common Stock | 10,000 | $3.9 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants that were previously reported. This sale is to satisfy mandatory non-discretionary tax withholding obligations by a "sell to cover" transaction. |
| F2 | The option exercise reported in this Form 4 was effect ted pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and exercised from a previously reported total. |
| F3 | The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. |